Financials Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 08:54:03 2024-12-03 am EST			5-day change	1st Jan Change
733.00 ^DKK	+0.83%		+1.59%	+96.81%

Nov. 21	Zealand Pharma A/S Presents at Jefferies London Healthcare Conference 2024, Nov-21-2024 09:30 AM
Nov. 20	KBC Securities Initiates Zealand Pharma at Buy	MT

Projected Income Statement: Zealand Pharma A/S

income-statement-evolution-chart ZEALAND-PHARMA-A-S

Fiscal Period: Dezember	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	41.3	353.3	292.6	104	342.8	377.7	1,766	3,171
Change	-	755.48%	-17.19%	-64.46%	229.65%	10.18%	367.6%	79.55%
EBITDA ¹	-574.3	-749.7	-1,012	-719.2	-547.2	-771.1	585.5	2,174
Change	-	30.55%	35.01%	-28.94%	-23.92%	-40.93%	-	271.27%
EBIT ¹	-587.9	-792.4	-1,052	-837.2	-572.2	-894.7	25.8	1,159
Change	-	34.78%	32.81%	-20.45%	-31.64%	-56.35%	-	4,391.54%
Interest Paid ¹	11.26	-47.29	-	-56.46	-136.6	-136.6	-126	-127.2
Earnings before Tax (EBT) ¹	-576.7	-839.7	-1,027	-972	-708.9	-734.5	743.4	2,284
Change	-	45.6%	22.31%	-5.35%	-27.07%	-3.62%	-	207.22%
Net income ¹	-571.5	-846.7	-1,018	-1,202	-703.7	-774.4	220.3	1,527
Change	-	48.15%	20.24%	18.07%	-41.46%	-10.04%	-	593.41%
Announcement Date	3/11/20	3/11/21	3/10/22	3/1/23	2/27/24	-	-	-

¹DKK in Million

Estimates

Fiscal Period: december	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	11.5	12.42	221	56.53	63.36	47.82	84.33	106.4	54.02	50.79	50.21	43.71	23.92	13.63	10.41	295.5	23.24	15.09	34.13	4.415	37.31	579.4	145.5	29.95	4,208
Change	-	7.97%	1,679.95%	-74.42%	12.08%	-24.52%	76.34%	26.19%	-49.24%	-5.98%	-1.14%	-12.93%	-45.27%	-43.04%	-23.64%	2,739.6%	-92.14%	-35.06%	126.2%	-87.06%	745.16%	1,452.84%	-74.88%	-79.42%	13,950.42%
EBITDA	-172.1	-	-	-	-326.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-100%	-	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-185.8	-177.2	-53.71	-218.2	-343.2	-260.9	-289.9	-211.8	-289.7	-343.4	-293.3	-162.1	-241	-168.7	-195.4	45.28	-253.5	-255.8	-267.7	-349.4	-359.2	-227.8	-239.8	-588.6	-671.3
Change	-	-4.63%	-69.69%	306.27%	57.3%	-23.99%	11.12%	-26.94%	36.8%	18.52%	-14.6%	-44.73%	48.68%	-30%	15.82%	-	-	0.93%	4.63%	30.53%	-2.79%	36.57%	-5.24%	-145.5%	-14.05%
Charge d'intérêts ¹	-9.05	-	-	-9.746	-	19.84	-14.39	-	3.91	133	-194.9	8.418	-19.75	-26.65	-125.7	27.55	-11.84	25.84	-26.39	-81.64	-27.5	-28	-28.6	-29.1	-29.7
Earnings before Tax (EBT) ¹	-194.9	-180.4	-59.56	-228	-371.8	-241.1	-304.3	-195.7	-285.8	-210.4	-488.5	-153.7	-322.4	-195.3	-321	72.83	-265.3	-230	-294.1	-267.8	-276	-	-	-	-
Change	-	-7.4%	-67%	282.75%	63.1%	-35.16%	26.24%	-35.68%	46.03%	-26.4%	132.23%	-68.55%	109.84%	-39.42%	64.37%	-	-	-13.31%	27.86%	-8.94%	-3.07%	100%	-	-	-
Net income ¹	-193.7	-179.5	-58.18	-228.6	-380.5	-242.2	-296.8	-198.9	-280.3	-222.8	-488.5	-148.3	-342.4	-193.6	-319.5	74.14	-264.8	-228.6	-292.8	-266.4	-320.6	-366.4	-428.1	-498.8	-579.6
Change	-	-7.31%	-67.59%	292.87%	66.49%	-36.36%	22.56%	-32.99%	40.92%	-20.49%	119.21%	-69.63%	130.85%	-43.46%	65%	-	-	-13.64%	28.04%	-9%	-20.36%	-14.27%	-16.84%	-16.5%	-16.21%
Announcement Date	3/11/20	5/14/20	8/13/20	11/12/20	3/11/21	5/12/21	8/12/21	11/11/21	3/10/22	5/12/22	8/11/22	11/10/22	3/1/23	5/11/23	8/17/23	11/9/23	2/27/24	5/16/24	8/15/24	11/7/24	-	-	-	-	-

¹DKK in Million

Estimates

Forecast Balance Sheet: Zealand Pharma A/S

balance-sheet-analysis-chart ZEALAND-PHARMA-A-S

Fiscal Period: december	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-1,381	-1,127	-907	-654	-1,633	-7,010	-7,902	-10,337
Change	-	-181.61%	-180.48%	-172.11%	-349.69%	-529.26%	-212.72%	-230.81%
Announcement Date	3/11/20	3/11/21	3/10/22	3/1/23	2/27/24	-	-	-

¹DKK in Million

Estimates

Cash Flow Forecast: Zealand Pharma A/S

Fiscal Period: december	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	21.04	25.04	22.13	11.71	11.24	14.02	15.55	14.1
Change	-	19.05%	-11.62%	-47.09%	-4.01%	24.7%	10.94%	-9.33%
Free Cash Flow (FCF) ¹	-430.5	-713.8	-1,234	-953.9	-436.9	-1,168	1,581	920.5
Change	-	65.8%	72.9%	-22.7%	-54.2%	167.4%	-235.3%	-41.77%
Announcement Date	3/11/20	3/11/21	3/10/22	3/1/23	2/27/24	-	-	-

¹DKK in Million

Estimates

Forecast Financial Ratios: Zealand Pharma A/S

Fiscal Period: december	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	-1,390.46%	-212.18%	-345.95%	-691.62%	-159.62%	-204.18%	33.16%	68.56%
EBIT Margin (%)	-1,423.49%	-224.27%	-359.7%	-805.06%	-166.94%	-236.89%	1.46%	36.55%
EBT Margin (%)	-1,396.31%	-237.65%	-351.01%	-934.78%	-206.79%	-194.49%	42.1%	72.03%
Net margin (%)	-1,383.88%	-239.65%	-348.01%	-1,156.05%	-205.3%	-205.04%	12.47%	48.17%
FCF margin (%)	-1,042.35%	-202.02%	-421.82%	-917.35%	-127.46%	-309.33%	89.5%	29.03%
FCF / Net Income (%)	75.32%	84.3%	121.21%	79.35%	62.08%	150.87%	717.56%	60.26%
Profitability
ROA	-40.4%	-50.38%	-53.17%	-	-	-19.45%	59.45%	-6.93%
ROE	-48.46%	-68.51%	-94.4%	-137.88%	-58.43%	-14.94%	-4.55%	-1.59%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	50.93%	7.09%	7.57%	11.26%	3.28%	3.71%	0.88%	0.44%
CAPEX / EBITDA (%)	-3.66%	-3.34%	-2.19%	-1.63%	-2.05%	-1.82%	2.66%	0.65%
CAPEX / FCF (%)	-4.89%	-3.51%	-1.79%	-1.23%	-2.57%	-1.2%	0.98%	1.53%
Items per share
Cash flow per share ¹	-12.11	-17.95	-28.3	-20.39	-7.522	-17.31	3.592	-7.167
Change	-	48.18%	57.66%	-27.94%	-63.12%	130.16%	-120.75%	-299.51%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	34.53	32.04	21.26	17.66	27.28	138.1	131.8	166.9
Change	-	-7.21%	-33.65%	-16.93%	54.47%	406.4%	-4.6%	26.64%
EPS ¹	-16.91	-22.07	-23.75	-26.02	-12.44	-12.42	1.272	17.44
Change	-	30.51%	7.61%	9.56%	-52.19%	-0.17%	-110.24%	1,271.52%
Nbr of stocks (in thousands)	35,990	39,735	43,216	51,470	58,374	70,647	70,647	70,647
Announcement Date	3/11/20	3/11/21	3/10/22	3/1/23	2/27/24	-	-	-